Business Description
Kenvue Inc
NAICS : 811490
SIC : 2842
ISIN : US49177J1025
Description
Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio includes a wide array of some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.12 | |||||
| Equity-to-Asset | 0.4 | |||||
| Debt-to-Equity | 0.83 | |||||
| Debt-to-EBITDA | 3.45 | |||||
| Interest Coverage | 5.22 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.39 | |||||
| Beneish M-Score | -2.5 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.9 | |||||
| 3-Year EBITDA Growth Rate | -4.6 | |||||
| 3-Year EPS without NRI Growth Rate | -2 | |||||
| 3-Year FCF Growth Rate | -4.5 | |||||
| 3-Year Book Growth Rate | -15.5 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 2.64 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 13.33 | |||||
| 9-Day RSI | 29.04 | |||||
| 14-Day RSI | 38.39 | |||||
| 3-1 Month Momentum % | 7.21 | |||||
| 6-1 Month Momentum % | 31.24 | |||||
| 12-1 Month Momentum % | 16.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1 | |||||
| Quick Ratio | 0.69 | |||||
| Cash Ratio | 0.18 | |||||
| Days Inventory | 103.89 | |||||
| Days Sales Outstanding | 51.83 | |||||
| Days Payable | 135.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.61 | |||||
| Dividend Payout Ratio | 0.68 | |||||
| Forward Dividend Yield % | 3.78 | |||||
| 5-Year Yield-on-Cost % | 3.61 | |||||
| 3-Year Average Share Buyback Ratio | -0.5 | |||||
| Shareholder Yield % | -1.76 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 57.78 | |||||
| Operating Margin % | 16.46 | |||||
| Net Margin % | 6.88 | |||||
| FCF Margin % | 9.08 | |||||
| ROE % | 9.94 | |||||
| ROA % | 3.92 | |||||
| ROIC % | 8.4 | |||||
| 3-Year ROIIC % | 32.03 | |||||
| ROC (Joel Greenblatt) % | 96.96 | |||||
| ROCE % | 8.95 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 40.58 | |||||
| Forward PE Ratio | 18.52 | |||||
| PE Ratio without NRI | 18.76 | |||||
| PS Ratio | 2.77 | |||||
| PB Ratio | 4.02 | |||||
| Price-to-Free-Cash-Flow | 30.58 | |||||
| Price-to-Operating-Cash-Flow | 22.28 | |||||
| EV-to-EBIT | 26.43 | |||||
| EV-to-Forward-EBIT | 14.6 | |||||
| EV-to-EBITDA | 19.76 | |||||
| EV-to-Forward-EBITDA | 14.36 | |||||
| EV-to-Revenue | 3.27 | |||||
| EV-to-Forward-Revenue | 3.15 | |||||
| EV-to-FCF | 36.09 | |||||
| Earnings Yield (Greenblatt) % | 3.78 | |||||
| FCF Yield % | 3.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kenvue Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 14,173.201 | ||
| EPS (TTM) (€) | 0.502 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 27.44 | ||
| 14-Day RSI | 38.39 | ||
| 14-Day ATR (€) | 0.408884 | ||
| 20-Day SMA (€) | 22.13125 | ||
| 12-1 Month Momentum % | 16.6 | ||
| 52-Week Range (€) | 16.082 - 23.5 | ||
| Shares Outstanding (Mil) | 1,917.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kenvue Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kenvue Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kenvue Inc Frequently Asked Questions
What is Kenvue Inc(FRA:J4D)'s stock price today?
The current price of FRA:J4D is €20.70. The 52 week high of FRA:J4D is €23.50 and 52 week low is €16.08.
When is next earnings date of Kenvue Inc(FRA:J4D)?
The next earnings date of Kenvue Inc(FRA:J4D) is 2025-02-07 Est..
Does Kenvue Inc(FRA:J4D) pay dividends? If so, how much?
The Dividend Yield %  of Kenvue Inc(FRA:J4D) is 3.61% (As of Today), Highest Dividend Payout Ratio of Kenvue Inc(FRA:J4D) was 0.68. The lowest was 0.31. And the median was 0.31. The  Forward Dividend Yield % of Kenvue Inc(FRA:J4D) is 3.78%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers